BOTHELL, Wash., Nov. 21, 2016 /PRNewswire/ -- (Booth #6713, North Building, Hall B) -- FUJIFILM SonoSite Inc., specialistsin developing cutting-edge ultrasound solutions and providing world-leading education to enable point-of-care visualization access, will present its innovative portfolio of ultrasound solutions and highlight enhanced features and upgrades at the 102nd
"We designed FUJIFILM SonoSite products to meet the needs of a wide range of point-of-care scenarios including some of the most demanding," said Diku Mandavia, MD, FACEP, FRCPC, chief medical officer and senior vice president, FUJIFILM SonoSite Inc. and FUJIFILM Medical Systems U.S.A., Inc. "Clinicians know they can trust Fujifilm technology when it comes to practical day-to-day use but also as tools that help them make rapid lifesaving decisions wherever they are—in the ED, OR or out in the field."
The following will be on exhibit and available for demonstration at RSNA Booth #6713:
SonoSite SII—Originally developed for regional anesthesia, vascular access and trauma applications, the SII empowers efficiency for clinicians through a simple, yet smart user interface that adapts to the user's imaging needs. The system is portable and can be used across multiple hospital environments, including a zero footprint option. The latest version of SII offers improved imaging technology and steep needle profiling. The SII also features DirectClear technology, a novel, patent-pending process that is now available on the rP19c and rC60xi transducers. DirectClear elevates transducer performance by increasing penetration and contrast resolution. Other new enhancements include a larger display with anti-reflection glass, greater storage capacity, updated system ports, an improved stand and armored cabling for durability.
SonoSite X-Porte—This highly portable system incorporates Extreme Definition Imaging (XDI™), a breakthrough, proprietary beam-forming technology that pinpoints precision so artifact clutter is dramatically reduced and contrast resolution is greatly enhanced. The system includes a user-friendly customizable touchscreen interface as well as real-time educational visual guides and tutorials. New features and functionality include additional customized worksheets as well as the ability to take measurements and calculations on a closed exam.
SonoSite iViz—Advancing Fujifilm's integration of ultrasound with medical IT, iViz was designed with ultra-mobility in mind. It allows seamless access to learning resources and patient information, as well as the ability to store exam findings, submit reports, and consult with remote providers for near real-time assessment, making it especially suited for field use and telemedicine. As a next generation architecture and platform, iViz is the first medical visualization solution that is enabled for bi-directional EMR connectivity through the Synapse® VNA. Using this option, iViz accepts patient demographics from the EMR, eliminating manual entry and saving valuable time. With just a few taps, iViz can also send patient reports to the EMR.
Vevo® MD—A groundbreaking technology, Vevo® MD is the world's first Ultra High Frequency ultrasound system for clinical use. The range of frequencies available (up to 70 MHz) results in unprecedented image resolution—down to 30 micrometers, which is less than half a grain of sand. With Vevo® MD, clinicians can see the smallest parts of anatomy, making it an ideal tool for imaging infants, identifying detecting tiny suspicious lesions, or monitoring subtle changes in blood flow in major arteries.
See Vevo MD in Action, Learn the Latest About Ultrasound
For the first time ever, Fujifilm will be performing live model scanning with Vevo® MD in Booth #6713. This is a rare and exciting opportunity for RSNA attendees to see the world's first ultra high-frequency ultrasound system for clinical use in action—on real people. Due to RSNA restrictions, onsite imaging scans will be limited to the head, neck, upper abdomen, and extremities.
In addition, attendees are encouraged to visit Fujifilm's In-Booth Healthcare Theater which will include two daily presentations on ultrasound topics: Ultra-High Frequency: A New Mode in Imaging and Ultra-Mobility in Imaging.
Register for a product demonstration at RSNA 2016 here:http://rsna.fujimed.com
For more information about FUJIFILM SonoSite, please visit: www.sonosite.com.
About FujifilmFUJIFILM SonoSite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by 26 subsidiaries and a global distribution network in over 100 countries. SonoSite's portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, go to: www.sonosite.com.
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2016, the company had global revenues of $22.1 billion, at an exchange rate of 112.54 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com
All product and company names herein may be trademarks of their registered owners.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/fujifilm-sonosite-showcases-comprehensive-portfolio-of-point-of-care-ultrasound-at-rsna-2016-300366563.html
SOURCE FUJIFILM SonoSite, Inc.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All